Model Number CP-023 |
Device Problem
Insufficient Information (3190)
|
Patient Problems
Cardiac Arrest (1762); Hemorrhage/Bleeding (1888); Cardiogenic Shock (2262)
|
Event Date 11/02/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Device remains implanted.
|
|
Event Description
|
The manufacturer became aware of the following event through mantra study.On (b)(6) 2022, carboseal valsalva conduit/valve cp-023 was implanted in aortic position through median sternotomy.The concomitant procedure was aortic root replacement (bentall procedure).Based on the x-ray performed on (b)(6) 2022, cardiac size remained enlarged with valvular prosthesis in place.Chest tube was seen on the right with no pneumothorax.Patchy bilateral airspace consolidation and some pleural fluid could be seen that was a little worse than the day before.Based on the x-ray performed on (b)(6) 2022, minor worsening of bibasilar airspace consolidation, with appearance of the chest otherwise unchanged from the x-ray performed on (b)(6) 2022.Reportedly, cardiac arrest and hemorrhage started on (b)(6) 2022.The outcome was indicated as recovered/resolved after patient underwent a surgical procedure: bedside - thoracotomy and then in operating room - mediastinum exploration; and other non-surgical procedure: bedside bronchoscopy.
|
|
Manufacturer Narrative
|
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.
|
|
Manufacturer Narrative
|
Since there is no allegation of device being explanted and the valve was not returned to the manufacturer for further investigation, the definitive root cause of the reported event cannot be established.However, from the document review performed, no manufacturing nor quality deficiencies were identified in the involved device.Should further information be received in the future, a follow up report will be provided.
|
|
Search Alerts/Recalls
|